Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial
PaperCitations, authors & open-access status
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 82 citations, 2012 year and hybrid oa status.
82
Citations
2012
Year
hybrid
OA Status